GE HealthCare Technologies Inc.GEHC
| Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net income | 1,614 | 2,050 |
|---|
| Less: Income (loss) from discontinued operations, net of taxes | -4 | - |
|---|
| Net income from continuing operations | 1,618 | 2,050 |
|---|
| Depreciation | 248 | 268 |
|---|
| Amortization of intangible assets | 362 | 312 |
|---|
| Gain on fair value remeasurement of contingent consideration | -17 | -19 |
|---|
| Net periodic postretirement benefit plan (income) expense | -332 | -357 |
|---|
| Postretirement plan contributions | 357 | 332 |
|---|
| Share-based compensation | 114 | 125 |
|---|
| Provision for income taxes | 743 | 531 |
|---|
| Cash paid during the year for income taxes | 474 | 491 |
|---|
| Receivables | 185 | 178 |
|---|
| Due from related parties | -4 | -25 |
|---|
| Inventories | -111 | 81 |
|---|
| Contract and other deferred assets | -10 | -3 |
|---|
| Accounts payable | -13 | 126 |
|---|
| Due to related parties | -84 | -61 |
|---|
| Contract liabilities | 26 | 68 |
|---|
| Current compensation and benefits | - | 39 |
|---|
| All other operating activities – net | 327 | -74 |
|---|
| Cash from (used for) operating activities – continuing operations | 2,101 | 1,955 |
|---|
| Additions to property, plant and equipment and internal-use software | 387 | 401 |
|---|
| Dispositions of property, plant, and equipment | 1 | - |
|---|
| Purchases of businesses, net of cash acquired | 147 | 313 |
|---|
| Purchases of investments | - | 40 |
|---|
| All other investing activities – net | 25 | 160 |
|---|
| Cash from (used for) investing activities – continuing operations | -558 | -914 |
|---|
| Net increase (decrease) in borrowings (maturities of 90 days or less) | -12 | - |
|---|
| Proceeds from Debt, Maturing in More than Three Months | 2,006 | 995 |
|---|
| Repayments and other reductions (maturities longer than 90 days) | 855 | 1,418 |
|---|
| Dividends paid to stockholders | 41 | 55 |
|---|
| Redemption of noncontrolling interests | 211 | - |
|---|
| Net transfers (to) from GE | -1,317 | - |
|---|
| Proceeds from stock issued under employee benefit plans | - | 33 |
|---|
| Taxes paid related to net share settlement of equity awards | - | 93 |
|---|
| All other financing activities – net | -48 | -34 |
|---|
| Cash from (used for) financing activities – continuing operations | -478 | -573 |
|---|
| Cash from (used for) operating activities – discontinued operations | - | -4 |
|---|
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | -10 | -77 |
|---|
| Increase (decrease) in cash, cash equivalents, and restricted cash | 1,055 | 387 |
|---|
| Cash paid during the year for interest | 570 | 550 |
|---|
| Capital Expenditures Incurred but Not yet Paid | 140 | 143 |
|---|